Method for predicting therapeutic efficacy of aphobazolum anxiolytic in patients with anxiety disorders
RU2707301C1
Low-molecular mimetic bdnf as an agent for treating opioid dependence
RU2734240C2
Diphenylpyrrolo[1,2-a]pyrazine-3-carboxamides-compounds having neuropsychotropic activity, methods for preparing them
RU2740754C1
Pharmaceutical composition of neuroprotective action for oral administration based on hexamethylene amide bis-(n-monosuccinyl-1-glutamyl-l-lysine) (versions), made in form of a tablet dispersible in the oral cavity
RU2744758C2
Dibenzofuran oxime derivants with anticonvulsant and neuroprotective activity
RU2709013C1
Use of amide n-(6-phenylhexanoyl) glycyl-l-tryptophane (gb-115) as an agent having anxiolytic properties with an activating component
RU2686672C1
Agent with antitumour and antimetastatic activity, anti-inflammatory and antiallergic action
RU2744681C1
Translational model of chronic heart failure: the method and criteria of formation assessment
RU2697254C1
Pharmaceutical composition based on bis-(n-monosuccinyl-l-seryl-l-lysine) hexamethylenediamide (gsb-106)
RU2691636C1
Sigma-1 receptor agonist of 5-ethoxy-2-[2-(morpholino)ethylthio]-benzimidazole dihydrochloride and/or base - a novel agent for preventing sudden cardiac death in patients suffering alcoholic cardiomyopathy
RU2693479C2
Agent possessing antidiabetic activity
RU2643588C1
Means for opioid abstinence syndrome arresting
RU2666598C1
Agent for correcting autism spectrum disorders
RU2689396C2
Pharmaceutical composition based on n-benzyl-n-methyl-1-phenylpyrrolo [1,2-a] pyrazine-3-carboxamide
RU2694837C2
Prolonged action pharmaceutical composition based on 5-ethoxy-2-[2-(morpholino)-ethylthio]benzimidazole dihydrochloride and/or base (aphobazolum)
RU2720510C2
Coumarin, thiocoumarin and quinolinone derivatives, having anticonvulsant activity
RU2678203C2
Pharmaceutical composition of neuroprotective action for parenteral application on basis of hexamethylenediamine bis-(n-monosuccinyl-l-glutamil-l-lysine) in lyophilized dosage form
RU2658833C1
Succinic acid esters of 5-hydroxyadamantan-2-one, improving blood supply to ischemic brain
RU2663452C1
Pharmaceutical composition in gel medicinal form for local use on the basis of n-(2-adamantil)-hexamethylenemine hydrochloride
RU2699658C2
Acylhydrazone (2,3,4-trimethoxy-n'-(8-methyl-8-azabicyclo[3.2.1.]octane-3-ylidene) benzohydrazide hydrochloride), having antimigraine and anxiolytic activity
